TLR4 and COVID-19: In COVID-19 an immunopathological process has been described that at least theoretically could be explained in part from the interaction of SP with TLR-4, increasing the production of inflammatory cytokines secondary to the formation of interfaces composed of antigenic residues of SP, interacting with external residues of TLR-4 [168].